CRDL CRDL
Company Profile ↓Company Overview
CRDL (CRDL) is a publicly traded company listed on with a market capitalization of $134.34M. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Growth & Price Performance
Stock Price Performance
| 1 Year: | +4.69% |
| 6 Months: | +31.37% |
| 3 Months: | +2.29% |
| 1 Month: | +32.67% |
- Price vs 50-DMAAbove
- Price vs 200-DMAAbove
- RSI (14)64.67 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
No notable concerns flagged.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Revenue | - | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - |
| Operating Expenses | - | 8.43M | 7.68M | 10.18M | 8.03M | 9.71M |
| Operating Income | - | -8.43M | -7.68M | -10.18M | -8.03M | -9.71M |
| EBITDA | - | -8.40M | -7.65M | -10.15M | -8.00M | -9.68M |
| Interest Expense | - | - | - | - | - | - |
| Pretax Income | - | -8.29M | -8.35M | -9.96M | -7.21M | -10.82M |
| Tax Provision | - | - | - | - | - | - |
| Net Income | - | -8.29M | -8.35M | -9.96M | -7.21M | -10.82M |
| Diluted EPS | - | -0.10 | -0.10 | -0.12 | - | -0.10 |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Revenue | - | 0 | 0 | 0 | 0 |
| Cost of Revenue | - | - | - | - | - |
| Gross Profit | - | - | - | - | - |
| Operating Expenses | - | 41.34M | 29.79M | 40.28M | 34.32M |
| Operating Income | - | -41.34M | -29.79M | -40.28M | -34.32M |
| EBITDA | - | -41.12M | -29.54M | -39.90M | -34.21M |
| Interest Expense | - | - | - | - | - |
| Pretax Income | - | -30.93M | -28.13M | -36.68M | -33.82M |
| Tax Provision | - | - | - | - | - |
| Net Income | - | -30.93M | -28.13M | -36.68M | -33.82M |
| Diluted EPS | - | -0.49 | -0.44 | -0.51 | -0.39 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Total Assets | - | 62.03M | 36.70M | 31.86M | 23.62M |
| Current Assets | - | 61.44M | 36.15M | 31.67M | 23.50M |
| Cash & Equivalents | - | 59.47M | 34.93M | 30.58M | 21.42M |
| Inventory | - | - | - | - | - |
| Receivables | - | 209.92K | 142.75K | 100.37K | 55.73K |
| Total Liabilities | - | 9.83M | 8.45M | 7.14M | 5.74M |
| Current Liabilities | - | 9.80M | 8.30M | 7.01M | 5.66M |
| Long Term Debt | - | - | - | - | - |
| Total Debt | - | 72.87K | 174.34K | 158.53K | 125.52K |
| Total Equity | - | 52.20M | 28.25M | 24.73M | 17.88M |
| Shares Outstanding | - | 64.04M | 65.35M | 82.61M | 100.26M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | -27.22M | -25.18M | -25.06M | -23.85M |
| Investing Cash Flow | - | -74.71K | -64.31K | -21.29K | -24.48K |
| Financing Cash Flow | - | -53.93K | -55.38K | 18.84M | 15.54M |
| Capital Expenditure | - | -74.71K | -64.31K | -21.29K | -24.48K |
| Free Cash Flow | - | -27.30M | -25.24M | -25.08M | -23.88M |
| Net Change in Cash | - | -27.35M | -25.30M | -6.24M | -8.34M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Gross Margin % | - | - | - | - | - |
| Operating Margin % | - | - | - | - | - |
| Net Margin % | - | - | - | - | - |
| ROE % | - | -59.3% | -99.6% | -148.3% | -189.2% |
| ROCE % | - | -79.2% | -104.9% | -162.1% | -191.0% |
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for CRDL
Cardiol Therapeutics to Join Boston Chat on Heart Disease Therapies - Stock Titan
<a href="https://news.google.com/rss/articles/CBMivAFBVV95cUxQWGVzRko3ZHpXYlZIQ0RaSUQwZURGeE5CdThVR3hSS3FvclcwU3liWFdaZ25TSEl2ckhfbnRmeEE1N3F5QTZuSnMyVXBrZGZMZTRsU2JKamtuT2RrdkhaSXR3U1E5Nk1HSnljWC15ZThvT3h6WTI2ZDVOUnBPRmFob05mcWtlaUlFQ0hrcD…
CRDL Stock Price, Quote & Chart - ChartMill
<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE5GbXg2UUFVY0pFRTBTTmNnTU9fcENFWjNkNFJIazJhT2hhRmdhR3g5Z1l5UDJVOTBpQWRNa2RiOThtaVlWYjRVR2ppMHJWRjBDWnJab3ROX05BUEVvN2Z3?oc=5" target="_blank">CRDL Stock Price, Quote & Chart</a>&nbs…
CRDL Forecast — Price Target — Prediction for 2027 - TradingView
<a href="https://news.google.com/rss/articles/CBMidkFVX3lxTE9HVnNSamZ4Q012M1U1a21nMzRVaGJmNDhrTmU4bGRSbkh1UWVkRDZrRjJRTWMwLUVCal9jRm84YzRSX1FYVnZIQmdvRnlEck5GRkt5Y25fMmIxRGpkLTIxX0prekpOb0Z4Mml2dTlGWGRPeDZRRVE?oc=5" target="_blank">CRDL For…
Cardiol Therapeutics Inc. (NASDAQ: CRDL) at Canaccord 46th Growth Conference - Stock Titan
<a href="https://news.google.com/rss/articles/CBMivAFBVV95cUxOZU5RQVRRcjFWUkpmSF9JbDBlTW1KU1FvQzEtS0oxN1Q1ck9Jb3FnR09oWXdIYzRBSGdsRFFseXhqMTR5WWlyOVJVODdyVzNhanRST1NobThRWi1MbVJjMS15Sm56VE85OHF2NkJmeVJvYUxPRldjZkRMSTl3TjE3UEdjaFZCNmtVSHNNLU…
Analysts Expect Breakeven For Cardiol Therapeutics Inc. (TSE:CRDL) Before Long - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMilwFBVV95cUxOTW1hcHZDMzN4dEU1TmNEcFJ0cnZsMVo3eUJONmZxMWoyM1BsWXlzUEdDRFQ1RjktMy0xRVdXcWJKWXJmSzE3RmgtYnhSaGhNYVRkWC10QVZLOU9WMVo5ekxHZUlBUkIydlRwSndKOVZVbUhTSnI0RzMxR1pucldmX1BvbnlHdjV0NXVTYn…
CRDL Should I Buy - Intellectia AI
<a href="https://news.google.com/rss/articles/CBMiXkFVX3lxTE1hbjJBQ0NzRkhvZjVPS3BBcnZDR3hRckRkR0I3T0o4R0xJd2FvVF9OMVUtLWFqSHJlVTVNdXlsZXROektRbDluX0ViX2w2OFRHd1BXSzAwM1J4MkNkZ0E?oc=5" target="_blank">CRDL Should I Buy</a> <font c…
CRDL — Frequently Asked Questions
What is the current share price of CRDL?
As of 2026-08-05 17:25 PDT, CRDL trades at $1.34 on NASDAQ/NYSE. Its 52-week range is $0.93 to $1.63.
What is the market capitalisation of CRDL?
CRDL has a market capitalisation of $134.34M on NASDAQ/NYSE.
What is the P/E ratio of CRDL?
CRDL trades at a trailing price-to-earnings (P/E) ratio of -3.44. Its price-to-book (P/B) ratio is 7.52.
Is CRDL a good stock to buy?
This page provides a data-driven analysis of CRDL, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.